Turtle Beach’s Groundbreaking & Critically Acclaimed Designed for Xbox Stealth Ultra Wireless Controller Launches Globally
Magnetic Hall Effect Thumbsticks, Precise Microswitch Buttons, Adjustable Triggers, the Unique Connected Command Display & More Provide Pro-Level Control &... Read more.
ICE Reports Record Total Futures and Options Open Interest of 86 Million Contracts
LONDON & AMSTERDAM & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of data, technology, and... Read more.
Unit Corporation Announces Ex-Dividend Date
TULSA, Okla.–(BUSINESS WIRE)–Unit Corporation (OTCQX: UNTC) (Company) previously announced three fourth quarter dividends, each to be paid on December... Read more.
Atomic AI Creates First Large Language Model Using Chemical Mapping Data to Optimize RNA Therapeutic Development
Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exploited to evaluate... Read more.
Global Branded PAH Therapeutics Market Report 2023: Analysis by Drug Class, RoA, Distribution – Market Insights and Forecasts 2019-2029 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Branded PAH Therapeutics Market (2023 Edition) – Analysis By Drug Class, Route of Administration, Distribution... Read more.
Kinetik Announces $200 Million Private Placement of Additional 6.625% Sustainability-Linked Senior Notes due 2028
HOUSTON & MIDLAND, Texas–(BUSINESS WIRE)–Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik”) announced today that its subsidiary, Kinetik Holdings... Read more.
Black Americans face discrimination in business social media – New EPoS Research Reveals
Field study on LinkedIn in the U.S. MANNHEIM, Germany–(BUSINESS WIRE)–Black Americans face higher initial barriers when using online business networks... Read more.
Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
If Approved, HYQVIA Would Offer an up to Once-Monthly Facilitated Subcutaneous At-Home or In-Office Treatment Option Positive Opinion Based on Phase 3 ADVANCE-CIDP... Read more.
Ladder Capital Corp Announces Fourth Quarter 2023 Dividend to Holders of Class A Common Stock
NEW YORK–(BUSINESS WIRE)–Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) today announced the declaration by its board of directors... Read more.
Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
– If approved by the European Commission, patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thalassemia, for... Read more.